The expression of CD58 is markedly elevated in Burkitt’s Lymphoma (BL) compared to BCP-ALL, and it can be used to aid in the diagnosis when BL is suspected but MYC proto-oncogene (C-MYC) rearrangement is negative and the results of surface Ig assessment are controversial (79). This evidence concerns the gene CD58 and acute lymphoblastic leukemia.